Article Text
Editorial
Periprocedural type IVa myocardial infarction and the importance of platelet inhibition
Statistics from Altmetric.com
Footnotes
-
Contributors All authors contributed to writing the manuscript.
-
Funding British Heart Foundation Chair (CH/09/002), Intermediate Fellowship (FS/10/024/28266) and Clinical Research Scholarship (SS/CH/09/002).
-
Competing interests NLM has received honoraria from Abbott Diagnostics and acted as a consultant for Beckman-Coultar and Abbott Diagnostics. All other authors have no competing interests or financial disclosures to declare.
-
Provenance and peer review Commissioned; internally peer reviewed.